Personal Information
Entreprise/Lieu de travail
Oslo Area, Norway Norway
Profession
PHD Candidate
Secteur d’activité
Medical / Health Care / Pharmaceuticals
À propos
The Norwegian Institute of Public Health is conducting an R&D-project called “Strengthening International Collaboration for Capitalizing on Cost-Effective and Life-Saving Commodities" (i4C), researching methodologies and policy interventions for how international actors can better collaborate globally to capitalize on cost-effective and life-saving medical commodities.
This PhD, which is part of the larger scale research project i4C, examines why a systematic approach to prioritization of investments in global health R&D is needed, by assessing why and how current approaches do not work; identifying the motivations behind different actors investing in global health R&D; and investiga...
Mots-clés
r&d priority setting; r&d investment decision maki
vaccine introduction
scale up production
manufacturing costs
product development
evd
market shaping
vaccines
ebola
Tout plus
Personal Information
Entreprise/Lieu de travail
Oslo Area, Norway Norway
Profession
PHD Candidate
Secteur d’activité
Medical / Health Care / Pharmaceuticals
À propos
The Norwegian Institute of Public Health is conducting an R&D-project called “Strengthening International Collaboration for Capitalizing on Cost-Effective and Life-Saving Commodities" (i4C), researching methodologies and policy interventions for how international actors can better collaborate globally to capitalize on cost-effective and life-saving medical commodities.
This PhD, which is part of the larger scale research project i4C, examines why a systematic approach to prioritization of investments in global health R&D is needed, by assessing why and how current approaches do not work; identifying the motivations behind different actors investing in global health R&D; and investiga...
Mots-clés
r&d priority setting; r&d investment decision maki
vaccine introduction
scale up production
manufacturing costs
product development
evd
market shaping
vaccines
ebola
Tout plus